Fairmount Funds Management Llc
Affiliations
- Large Shareholder, Director at Glycomimetics Inc (CBIO), 2025-06-23
- Director at Apogee Therapeutics Inc. (APGE), 2025-06-21
- Director at Zenas Biopharma Inc. (ZBIO), 2025-06-12
- Large Shareholder, Director at Viridian Therapeutics Inc. (VRDN), 2025-06-11
- Large Shareholder, Director at Oruka Therapeutics Inc. (ORKA), 2025-06-03
- Director at Spyre Therapeutics Inc. (SYRE), 2025-06-02
- at Jade Biosciences Inc. (JBIO), 2025-05-01
- Director at Dianthus Therapeutics Inc. (DNTH), 2024-10-02
- at Cogent Biosciences Inc. (COGT), 2024-06-13
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| VRDN | $18.75 | 1,600,000 | $30,000,000.00 | 3,445,813 | 2024-09-13 | Filing |
| ZBIO | $17.00 | 300,000 | $5,100,000.00 | 1,892,806 | 2024-09-16 | Filing |
| ZBIO | $17.00 | 300,000 | $5,100,000.00 | 1,604,891 | 2024-09-16 | Filing |
| VRDN | $21.00 | 476,190 | $9,999,990.00 | 1,839,954 | 2024-01-22 | Filing |
| DNTH | $13.63 | 24,670 | $336,252.10 | 1,928,503 | 2023-09-29 | Filing |